APT Therapeutics

APT Therapeutics is a drug discovery company developing a therapy for the treatment of thrombotic diseases. It applies proprietary protein engineering strategies to develop a human apyrase therapy for the treatment of acute myocardial infarction, stroke, pulmonary arterial hypertension, and transplantation complications.